Phase 4 study: an open prospective study of the safety and effectiveness of aripiprazole in the treatment of bipolar depression

Trial Profile

Phase 4 study: an open prospective study of the safety and effectiveness of aripiprazole in the treatment of bipolar depression

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 23 Jun 2008 The expected completion date for this trial is now 1 Mar 2007.
    • 18 Jun 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top